SEE AMAZON.COM DEALS FOR TODAY
Accident – Death – Obituary News : : 1. Coronary artery disease diagnosis technology
2. Cardiac health AI diagnostics
Heart & Lung Health (HLH), a UK-wide network of expert cardiothoracic radiologists, has partnered with Caristo Diagnostics to deploy the groundbreaking CaRi-Heart® AI solution. This technology predicts patients’ risk of developing coronary artery disease, addressing a crucial need in the UK where millions present with chest pain annually. Caristo’s technology detects coronary inflammation, a key risk factor often missed in traditional scans, providing a patented biomarker for early diagnosis. The partnership aims to save lives by offering this innovative technology across multiple UK sites. With RadNet’s backing, HLH and Caristo are set to revolutionize cardiac health assessment in the UK. In this article, we will discuss the importance of SEO and how it can benefit your website. SEO, or search engine optimization, is crucial for improving your website’s visibility and driving organic traffic. By optimizing your site’s content, keywords, and meta tags, you can increase your chances of ranking higher on search engine results pages. This, in turn, can lead to more clicks, visits, and ultimately, conversions. With the right SEO strategy in place, you can attract more potential customers and grow your online presence. Stay tuned as we dive deeper into the world of SEO and provide valuable tips for optimizing your website.
You may also like to watch : Who Is Kamala Harris? Biography - Parents - Husband - Sister - Career - Indian - Jamaican Heritage
This is a summary of the content you provide. Please provide the content that needs to be summarized.
The UK-Wide Radiologist Network Embraces Caristo’s Revolutionary CaRi-Heart® Solution
OXFORD, England, March 19, 2024 /PRNewswire/ — Heart & Lung Health (HLH), , a UK-wide network of over 110 expert cardiothoracic radiologists, has joined forces with Caristo Diagnostics, a leading cardiac disease diagnostics company, to introduce the innovative CaRi-Heart® AI technology. This groundbreaking technology aims to predict patients’ risk of developing potentially fatal coronary artery disease.
You may also like to watch: Is US-NATO Prepared For A Potential Nuclear War With Russia - China And North Korea?
The Challenge of Predicting Heart Disease
Each year, an estimated 1 million adults in the UK experience chest pain, prompting them to seek medical attention. Many of these individuals will undergo a coronary computed tomography angiography (CCTA) scan to diagnose coronary artery disease, which is often caused by plaques that narrow or block the arteries supplying blood to the heart. Surprisingly, three-quarters of patients undergoing CCTAs show no signs of significant artery narrowing, leading them to be classified as low-risk for heart attacks. However, these “low-risk” patients actually face twice the risk of death or cardiac events compared to high-risk individuals. This increased risk is often due to coronary inflammation, a critical factor not previously detectable in routine CCTAs.
A Revolutionary Solution
Caristo’s CaRi-Heart® technology, developed based on research originating at the University of Oxford, is a pioneering AI solution that can now identify coronary inflammation during routine CCTAs. By assessing coronary inflammation and integrating plaque and clinical risk factors such as cholesterol levels, this technology provides a non-invasive Fat Attenuation Index Score™ (FAI-Score™) as a patented biomarker for coronary inflammation.
Transforming Patient Care
Studies have shown that patients with abnormal CaRi-Heart® test results, even if initially free of plaque and calcium, face significantly higher risks of cardiac mortality and major adverse cardiac events. In light of these findings, HLH will incorporate the CaRi-Heart® AI-based cardiac assessment as part of their cardiac health check package at multiple locations throughout the UK. The network, known for its expert cardiothoracic radiologists specializing in lung and cardiac conditions, serves the NHS and various hospitals and academic institutions. Each patient screened with CaRi-Heart® will receive personalized care from their consulting cardiologist or family doctor based on the technology’s findings.
“At HLH, our mission is to provide fast and accurate imaging reports that prioritize patient well-being. We are excited to expand access to the award-winning CaRi-Heart® AI technology across all our UK sites. By identifying patients at risk of heart attacks early on, we have the potential to save countless lives,” Dr. Jonathan Rodrigues, Chief Medical Officer & Co-Founder of Heart & Lung Health.
A Collaborative Effort
In 2022, RadNet, Inc., a prominent U.S.-based diagnostic imaging services provider, acquired a majority stake in HLH. Together, RadNet and HLH aim to improve health outcomes for patients at risk of coronary artery disease by enhancing access to the CaRi-Heart® technology throughout the UK.
“Early diagnosis and interventions can significantly improve the health of patients at risk of coronary artery disease. We are delighted to partner with Heart & Lung Health to expand access to CaRi-Heart® technology for patients across the UK,” stated Frank Cheng, CEO of Caristo Diagnostics.
About Caristo Diagnostics
Caristo Diagnostics is a global leader in cardiac and vascular disease diagnostics and risk prediction. Established in 2018 as a spin-out from the University of Oxford, Caristo develops imaging-based and AI-assisted platforms to aid in the prediction and diagnosis of heart attack, stroke, and diabetes. The company has been recognized by Nature as one of the most promising science-based companies emerging from academic research.
Leading the Way in Cardiac Health
The CaRi-Heart® technology has been successfully integrated into clinical practice in various NHS and private hospitals in the UK, as well as in the EU and Australia. Recent research presented at the American Heart Association’s Late Breaking Science Sessions has highlighted the technology’s ability to predict cardiac events independently of standard clinical risk assessments and CCTA interpretations, revolutionizing the management of patients at risk of coronary artery disease.
For more information about Caristo Diagnostics, visit their website, LinkedIn, and Twitter.
About Heart & Lung Health
For inquiries, contact Frank Cheng, CEO of Caristo Diagnostics, at [email protected]
Source: Caristo Diagnostics
the latest advancements in artificial intelligence technology.
Artificial intelligence (AI) is advancing at a rapid pace, with new breakthroughs and innovations constantly being made in this field. From self-driving cars to virtual assistants, AI is revolutionizing the way we live and work. In recent years, there have been several key advancements in AI technology that are poised to shape the future of the industry.
One of the most exciting developments in AI is the rise of generative adversarial networks (GANs). GANs are a type of AI model that consists of two neural networks – a generator and a discriminator – that work together to create realistic and high-quality images, videos, and other media. This technology has been used in a variety of applications, such as creating deepfake videos and generating realistic images of people who do not exist.
Another key advancement in AI technology is the development of reinforcement learning algorithms. Reinforcement learning is a type of machine learning that enables AI systems to learn from their environment through trial and error. This technology has been used to develop sophisticated AI agents that can play complex games like chess and Go at a superhuman level. Reinforcement learning has also been applied to robotics, enabling robots to learn new tasks and skills through interaction with their environment.
Natural language processing (NLP) is another area of AI that has seen significant advancements in recent years. NLP is a branch of AI that focuses on enabling computers to understand and generate human language. With the development of transformer models like BERT and GPT-3, NLP has made great strides in tasks such as language translation, text generation, and sentiment analysis. These models have been used in a wide range of applications, from chatbots to content creation tools.
AI ethics and bias have also become important topics of discussion in the AI community. As AI systems become more powerful and pervasive, there is a growing concern about the ethical implications of their use. Issues such as bias in AI algorithms, data privacy, and the impact of AI on jobs are all hotly debated topics. Researchers and policymakers are working to develop guidelines and regulations to ensure that AI is used responsibly and ethically.
Looking ahead, the future of AI looks bright. As technology continues to evolve, we can expect to see even more powerful AI systems that can perform a wider range of tasks with greater accuracy and efficiency. From healthcare to finance to transportation, AI is poised to transform every industry and revolutionize the way we live and work.
In conclusion, the advancements in artificial intelligence technology are driving innovation and shaping the future of the industry. With breakthroughs in GANs, reinforcement learning, NLP, and AI ethics, AI is poised to revolutionize every aspect of our lives. As researchers and developers continue to push the boundaries of what is possible with AI, we can expect to see even more exciting developments in the years to come.
